Thank you for your continued support of the Health and Global Policy Institute (HGPI).
It is our pleasure to invite you to a special breakfast meeting detailed below that will feature Professor Kevin Outterson. As you may already know, Professor Outterson is one of the world’s leading experts on business models for antimicrobial drug development and use. He is Professor of Law and N. Neil Pike Scholar of Health and Disability Law at Boston University, and the Executive Director of CARB-X, the world’s largest public-private partnership to promote research and development of innovative therapeutics, preventatives and diagnostics for drug-resistant bacterial infections. During this session, Professor Outterson will share his experiences and discuss his views on push and pull incentives to promote AMR measures, the usefulness of Public Private Partnerships (PPPs) in global health, and expectations for Japan as the G7 host country in 2023. We will also be holding a discussion on these perspectives with everyone in attendance and would be honored if you joined us.

HGPI 49th Special Breakfast Meeting

Push and Pull Incentives to Address Antimicrobial Resistance
– The Experience of CARB-X and the potential for Public-Private Partnerships in Global Health

Guest speaker: Professor Kevin Outterson; Executive Director, CARB-X

• Cohost: Health and Global Policy Institute, CARB-X and AMR Alliance Japan
• Speaker:
  Professor Kevin Outterson (Executive Director, CARB-X)
  Kevin Outterson is a global thought leader on business models for antibiotic development and use. He is Professor of Law and N. Neil Pike Scholar of Health and Disability Law at Boston University School of Law, where he leads multi-disciplinary teams to solve global health issues. Professor Outterson is also the Executive Director and Principal Investigator of CARB-AB.